Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anja Irmisch

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Cancer Cell|April 17, 2019
γ-Catenin-Dependent Signals Maintain BCR-ABL1<sup>+</sup> B Cell Acute Lymphoblastic LeukemiaNoemie Luong-Gardiol, Imran Siddiqui, Irene Pizzitola, et al.
The EMBO Journal|July 4, 2019
Proteomic identification of a marker signature for MAPKi resistance in melanomaVerena Paulitschke, Ossia Eichhoff, Christopher Gerner, et al.
Med (New York, N.Y.)|April 9, 2024
Myeloid-T cell interplay and cell state transitions associated with checkpoint inhibitor response in melanomaRamona Schlenker, Petra C Schwalie, Steffen Dettling, et al.
Frontiers in Oncology|April 5, 2024
Phase 1, first-in-human study of TYRP1-TCB (RO7293583), a novel TYRP1-targeting CD3 T-cell engager, in metastatic melanoma: active drug monitoring to assess the impact of immune response on drug exposureAnna Spreafico, Eva Muñoz Couselo, Anja Irmisch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 4, 2019
A Fatty Acid Oxidation-dependent Metabolic Shift Regulates the Adaptation of <i>BRAF</i>-mutated Melanoma to MAPK InhibitorsAndrea Aloia, Daniela Müllhaupt, Christophe D Chabbert, et al.
Cancer Research|March 22, 2023
ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated MelanomaOssia M Eichhoff, Corinne I Stoffel, Jan Käsler, et al.
Cancer Cell|January 22, 2021
The Tumor Profiler Study: integrated, multi-omic, functional tumor profiling for clinical decision supportAnja Irmisch, Ximena Bonilla, Stéphane Chevrier, et al.
Nature Medicine|August 1, 2025
Publisher Correction: Feasibility of multiomics tumor profiling for guiding treatment of melanomaNicola Miglino, Nora C Toussaint, Alexander Ring, et al.
Nature Medicine|May 27, 2025
Feasibility of multiomics tumor profiling for guiding treatment of melanomaNicola Miglino, Nora C Toussaint, Alexander Ring, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Cancer Cell|April 17, 2019
γ-Catenin-Dependent Signals Maintain BCR-ABL1<sup>+</sup> B Cell Acute Lymphoblastic LeukemiaNoemie Luong-Gardiol, Imran Siddiqui, Irene Pizzitola, et al.
The EMBO Journal|July 4, 2019
Proteomic identification of a marker signature for MAPKi resistance in melanomaVerena Paulitschke, Ossia Eichhoff, Christopher Gerner, et al.
Med (New York, N.Y.)|April 9, 2024
Myeloid-T cell interplay and cell state transitions associated with checkpoint inhibitor response in melanomaRamona Schlenker, Petra C Schwalie, Steffen Dettling, et al.
Frontiers in Oncology|April 5, 2024
Phase 1, first-in-human study of TYRP1-TCB (RO7293583), a novel TYRP1-targeting CD3 T-cell engager, in metastatic melanoma: active drug monitoring to assess the impact of immune response on drug exposureAnna Spreafico, Eva Muñoz Couselo, Anja Irmisch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 4, 2019
A Fatty Acid Oxidation-dependent Metabolic Shift Regulates the Adaptation of <i>BRAF</i>-mutated Melanoma to MAPK InhibitorsAndrea Aloia, Daniela Müllhaupt, Christophe D Chabbert, et al.
Cancer Research|March 22, 2023
ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated MelanomaOssia M Eichhoff, Corinne I Stoffel, Jan Käsler, et al.
Cancer Cell|January 22, 2021
The Tumor Profiler Study: integrated, multi-omic, functional tumor profiling for clinical decision supportAnja Irmisch, Ximena Bonilla, Stéphane Chevrier, et al.
Nature Medicine|August 1, 2025
Publisher Correction: Feasibility of multiomics tumor profiling for guiding treatment of melanomaNicola Miglino, Nora C Toussaint, Alexander Ring, et al.
Nature Medicine|May 27, 2025
Feasibility of multiomics tumor profiling for guiding treatment of melanomaNicola Miglino, Nora C Toussaint, Alexander Ring, et al.
Pageof 2